Against the backdrop of the accelerating global aging process, authoritative institutions predict that by 2030, the global population aged 65 and above will soar to 1.4 billion. Meanwhile, the number of patients with chronic respiratory diseases is also surging—there are over 384 million patients with Chronic Obstructive Pulmonary Disease (COPD) alone. This large population has an ever-increasing demand for oxygen concentrators.

On May 20, 2025, Hebei Lixin Medical Engineering Co., Ltd. successfully won the bid for the "Concession Operation of Oxygen Supply Guarantee Project for Cadres and Employees in Markam County, Tibet" with a bid amount of 155,562,787.76 yuan. Currently, the project has entered the smooth equipment delivery phase.

In the vast system of modern industry, there is a type of equipment that rarely enters public view but silently supports the stable operation of numerous industries—it is the nitrogen generator.

In the post-pandemic era, people's attention to health has reached an unprecedented level, and indoor air quality has become a focal topic. According to data from the World Health Organization (WHO), as many as 92.5% of countries worldwide face excessive air pollution, with the average annual PM2.5 concentration in major regions such as North America, Europe, and the Asia-Pacific even exceeding the WHO standard by 3 times. This situation has directly driven the rapid development of the air purifier market, which is expanding at a compound annual growth rate of 10%. It is estimated that by 2031, the market size will soar to USD 32.1 billion.

In the post-pandemic era, people's attention to health has reached an unprecedented level, and indoor air quality has become a focal topic. According to data from the World Health Organization (WHO), as many as 92.5% of countries worldwide face excessive air pollution, with the average annual PM2.5 concentration in major regions such as North America, Europe, and the Asia-Pacific even exceeding the WHO standard by 3 times. This situation has directly driven the rapid development of the air purifier market, which is expanding at a compound annual growth rate of 10%. It is estimated that by 2031, the market size will soar to USD 32.1 billion.

Globally, the oxygen chamber market is showing a vigorous development trend. According to statistics from Hengzhou Chengsi Research, the global revenue scale of medical hyperbaric oxygen chambers reached approximately 14.84 billion yuan in 2024, and is expected to approach 20.84 billion yuan by 2031, with a compound annual growth rate (CAGR) of 5.0% from 2025 to 2031. In terms of regional distribution, Asia accounts for the main market share at 52.01%, becoming the core market for global medical hyperbaric oxygen chambers. This is mainly due to Asia's large population base and increasing attention to the medical and health field. North America follows closely with a 18.78% share, playing an important role in high-end applications and scientific research of hyperbaric oxygen chambers relying on its advanced medical technology and improved medical system. Europe accounts for 17.96%, and its developed medical industry and widespread recognition of rehabilitation treatment also provide stable development space for the oxygen chamber market.

Oxygen, as the cornerstone of life, plays an irreplaceable role in human health. At the cellular level, oxygen is a key element for cells to perform aerobic respiration, participating in the energy generation process and continuously providing energy for various life activities of the human body. Once oxygen is lacking, human physiological functions will be severely affected, and even life will be endangered.

Recently, the second-generation intelligent micro-hyperbaric oxygen chamber independently developed by Baoyang Four Seasons (Hengshui) Health Management Co., Ltd. has been highly recognized by European and American clients and successfully signed contracts. Clients from Europe and America made a special trip to the production base in Hebei to conduct on-site inspections, conduct in-depth exchanges on technical details and cooperation prospects, marking a crucial step for the company in its international expansion.

As the new year begins, everything takes on a new look. Hebei Lixin Medical Engineering Co., Ltd. sincerely launches the "All-Region Partner Program", looking forward to recruiting talented people from all over the country, and working with like-minded partners to open a new chapter in the medical and health industry.

Chronic bronchitis is a prevalent respiratory disease worldwide. According to statistics from the World Health Organization (WHO), there are approximately 100 million patients globally, with a prevalence rate of about 3% to 5% in China. It mainly affects middle-aged and elderly individuals, smokers, and those with long-term exposure to air pollution.

Hebei Lixin Medical Engineering Co., Ltd. is an integrated enterprise engaging in scientific research, development, design, manufacturing, service, and construction, specializing in the medical engineering field for more than 20 years.

Dragons return to the sea and soar for ten thousand miles; horses gallop into a new journey to initiate a great cause. As the Spring Festival of the Jiawu Year of the Horse approaches, Hebei Lixin Medical Engineering Co., Ltd. extends its most sincere greetings and best wishes to every colleague who has worked diligently and made selfless contributions over the past year, as well as to your families!

In the medical field, disinfection serves as a critical line of defense for safeguarding life and health. As the core weapon of this line of defense, the technological advancement and reliability of medical disinfectors are directly tied to the safety of both patients and medical staff. Leveraging cutting-edge technology, our medical disinfectors have ushered in a disruptive transformation in medical disinfection.